Close
Digital Health & Ai Innovation summit 2026
APE 2026

McKesson announces successful acquisition of System C

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

Natera Adds ctDNA-Based MRD Tests with...

In an all-stock transaction, Natera, which is the cell-free...

FDA Launches Technology-Enabled Meaningful Patient Outcomes

Technology-Enabled Meaningful Patient Outcomes – TEMPO has been launched...

US Healthcare Providers to Benefit from...

The federal government has formally withdrawn the Biden-era minimum...
McKesson is a leading distributor of medicines, medical supplies and healthcare information technology solutions that touch the lives of more than 100 million patients in every healthcare setting across the world. McKesson operates the NHS Electronic Staff Record (ESR), an integrated HR and payroll system responsible for the pay of 1.4m NHS employees across England and Wales. 

This acquisition combines System C’s next-generation Medway suite of clinical and administrative software and its proven volume deployment capability with McKesson’s client base, financial strength and reputation. Together, the companies are a major provider of IT to the NHS, independent and social care markets in the UK and internationally.

McKesson and System C employ 1200 people in Europe. Their joint product offering includes patient administration and electronic patient record (PAS/EPR) systems, A&E, maternity, child health, business intelligence, PACS, cardiology, adult and children’s social care systems, workforce management solutions and services, and a variety of clinical and commissioning applications.

Latest stories

Related stories

Natera Adds ctDNA-Based MRD Tests with Acquisition of Foresight Diagnostics

In an all-stock transaction, Natera, which is the cell-free...

FDA Launches Technology-Enabled Meaningful Patient Outcomes

Technology-Enabled Meaningful Patient Outcomes – TEMPO has been launched...

US Healthcare Providers to Benefit from Minimum Nurse Staffing Rule Repeal

The federal government has formally withdrawn the Biden-era minimum...

Purehealth, Dorchester Partner to Bring Luxury Hospitality in Healthcare

PureHealth has gone on to announce a first-of-its-kind partnership...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »